Leptomeningeal Neoplasms

BACKGROUND Nivolumab monotherapy and combination nivolumab plus ipilimumab increase proportions of patients achieving a response… Expand

Anti-CD47 antibody is effective for treating malignant pediatric brain tumors without detectable toxicity in patient-derived… Expand

Introduction: Afatinib is an effective first-line treatment in patients with epidermal growth factor receptor (EGFR)-mutated non… Expand

BACKGROUND Detecting tumor-derived cell-free DNA (cfDNA) in the blood of brain tumor patients is challenging, presumably owing to… Expand

Whole-brain dynamic time-resolved computed tomography angiography (CTA) is a technique developed on the new 320-detector row CT… Expand

BACKGROUND AND PURPOSE The role of noninvasive methods in the evaluation of collateral circulation has yet to be defined. We… Expand

IntroductionBrain metastases (BM) occur in up to one third of patients with metastatic breast cancer (MBC), whose incidences and… Expand

Abstract Diagnostic decision making in the case of patients suspected of having leptomeningeal metastasis (LM) can be very… Expand

The diagnosis of leptomeningeal metastasis is often difficult and usually requires the demonstration of malignant cells in the… Expand

The clinical findings and response to treatment of leptomeningeal metastases from solid tumors are analyzed in 90 patients… Expand